Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$0.39 - $0.54 $76,050 - $105,300
-195,000 Reduced 67.04%
95,859 $46,000
Q1 2023

May 15, 2023

SELL
$0.33 - $0.58 $5,676 - $9,977
-17,202 Reduced 5.58%
290,859 $110,000
Q4 2022

Feb 14, 2023

BUY
$0.33 - $12.0 $21,171 - $769,872
64,156 Added 26.3%
308,061 $101,000
Q3 2022

Nov 14, 2022

SELL
$0.68 - $11.25 $320,452 - $5.3 Million
-471,253 Reduced 65.89%
243,905 $183,000
Q2 2022

Aug 15, 2022

BUY
$0.81 - $3.43 $559,313 - $2.37 Million
690,511 Added 2801.6%
715,158 $652,000
Q1 2022

May 16, 2022

SELL
$2.27 - $4.13 $282,496 - $513,970
-124,448 Reduced 83.47%
24,647 $85,000
Q4 2021

Feb 14, 2022

BUY
$3.37 - $6.87 $64,592 - $131,677
19,167 Added 14.75%
149,095 $584,000
Q3 2021

Nov 15, 2021

SELL
$5.78 - $7.86 $40,338 - $54,854
-6,979 Reduced 5.1%
129,928 $872,000
Q2 2021

Aug 16, 2021

SELL
$7.82 - $12.44 $4.53 Million - $7.2 Million
-579,097 Reduced 80.88%
136,907 $1.07 Million
Q1 2021

May 17, 2021

BUY
$9.33 - $14.05 $2.52 Million - $3.79 Million
269,663 Added 60.42%
716,004 $9.04 Million
Q4 2020

Feb 16, 2021

SELL
$8.48 - $12.23 $3.32 Million - $4.79 Million
-392,013 Reduced 46.76%
446,341 $4.19 Million
Q3 2020

Nov 16, 2020

BUY
$9.99 - $14.41 $2.9 Million - $4.19 Million
290,435 Added 53.01%
838,354 $9.16 Million
Q2 2020

Aug 14, 2020

BUY
$12.28 - $17.63 $3.77 Million - $5.42 Million
307,363 Added 127.77%
547,919 $7.56 Million
Q1 2020

May 14, 2020

BUY
$11.31 - $18.26 $491,657 - $793,780
43,471 Added 22.06%
240,556 $3.2 Million
Q4 2019

Feb 14, 2020

BUY
$6.44 - $14.21 $1.27 Million - $2.8 Million
197,085 New
197,085 $2.76 Million
Q2 2019

Aug 14, 2019

SELL
$5.83 - $8.42 $370,653 - $535,318
-63,577 Closed
0 $0
Q1 2019

May 14, 2019

SELL
$4.02 - $5.81 $884,576 - $1.28 Million
-220,044 Reduced 77.58%
63,577 $369,000
Q4 2018

Feb 14, 2019

SELL
$3.35 - $5.68 $1.27 Million - $2.16 Million
-380,369 Reduced 57.29%
283,621 $1.15 Million
Q3 2018

Nov 14, 2018

BUY
$4.07 - $6.25 $2.51 Million - $3.86 Million
616,999 Added 1313.02%
663,990 $3.58 Million
Q2 2018

Aug 14, 2018

SELL
$5.19 - $9.71 $1.29 Million - $2.41 Million
-247,885 Reduced 84.06%
46,991 $246,000
Q1 2018

May 15, 2018

BUY
$8.0 - $12.96 $1.78 Million - $2.89 Million
222,817 Added 309.21%
294,876 $2.36 Million
Q4 2017

Feb 14, 2018

BUY
$7.04 - $11.31 $507,295 - $814,987
72,059
72,059 $722,000

Others Institutions Holding MTEM

About Molecular Templates, Inc.


  • Ticker MTEM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,351,600
  • Market Cap $7.33M
  • Description
  • Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform. The company is developi...
More about MTEM
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.